Emergent Biosolutions, Inc. News Headlines

EBS 
$22.62
*  
0.27
1.21%
Get EBS Alerts
*Delayed - data as of Oct. 31, 2014  -  Find a broker to begin trading EBS now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
3 Biotech Stocks With Humongous Short Interest
10/22/2014 9:05:02 AM - Motley Fool


Amicus Reports Additional Positive Data on Fabry Therapy - Analyst Blog
10/20/2014 6:35:00 PM - Zacks.com


Affymetrix-Ariosa Ink Supply Deal for Harmony Prenatal Test - Analyst Blog
10/20/2014 4:55:00 PM - Zacks.com


Infinity Pharmaceuticals' Duvelisib Fails in Mid-Stage Study - Analyst Blog
10/17/2014 5:00:00 PM - Zacks.com


Ultragenyx Reports Data from Sialic Acid Deficiency Study - Analyst Blog
10/17/2014 5:00:00 PM - Zacks.com


Gilead's Harvoni Receives Notice of Compliance from Canada - Analyst Blog
10/17/2014 4:30:00 PM - Zacks.com


What Falling Estimates & Price Mean for Enzo Biochem (ENZ) - Tale of the Tape
10/17/2014 8:57:00 AM - Zacks.com


Alexion (ALXN) Seeks Japanese Approval for Asfotase Alfa - Analyst Blog
10/16/2014 4:30:00 PM - Zacks.com


Agios (AGIO) Rises on Expansion of Phase I Study on AG-221 - Analyst Blog
10/16/2014 4:10:00 PM - Zacks.com


GW Pharmaceuticals Down on Disappointing Mid-Stage Data - Analyst Blog
10/15/2014 6:48:00 PM - Zacks.com


Novavax Begins Mid-Stage Study on RSV Vaccine in Elders - Analyst Blog
10/15/2014 5:20:00 PM - Zacks.com


Alnylam Reveals Positive Data from its Pipeline Candidates - Analyst Blog
10/15/2014 4:30:00 PM - Zacks.com


Alnylam Jumps on Positive Patisiran Data from Phase II Study - Analyst Blog
10/14/2014 4:45:00 PM - Zacks.com


Protalix BioTherapeutics, Inc. (PLX) in Focus: Stock Surges 11.4% - Tale of the Tape
10/14/2014 9:18:11 AM - Zacks.com


Alnylam Pharmaceuticals (ALNY) Jumps: Stock Rises 19% - Tale of the Tape
10/14/2014 9:04:00 AM - Zacks.com


Prosensa Holding N.V. (RNA) in Focus: Stock up 8.5% - Tale of the Tape
10/14/2014 8:44:00 AM - Zacks.com


Vical Incorporated (VICL) in Focus: Stock Soars 12% - Tale of the Tape
10/14/2014 8:43:59 AM - Zacks.com


Exact Sciences (EXAS) Looks Strong: Stock Surges 35.8% - Tale of the Tape
10/13/2014 8:44:00 AM - Zacks.com


Weakness Seen in Momenta Pharmaceuticals (MNTA): Stock Tumbles 13.5% - Tale of the Tape
10/13/2014 8:30:00 AM - Zacks.com


XOMA Starts Phase I Study on XOMA 358 for Hyperinsulinism - Analyst Blog
10/10/2014 5:10:00 PM - Zacks.com


Weakness Seen in Galena Biopharma (GALE) Estimates: Should You Stay Away? - Tale of the Tape
10/9/2014 9:00:00 AM - Zacks.com


Emergent BioSolutions Revamps Business to Drive Earnings - Analyst Blog
10/8/2014 5:50:00 PM - Zacks.com


Emergent BioSolutions Initiates Pivotal Study on BioThrax - Analyst Blog
9/24/2014 5:20:00 PM - Zacks.com


Emergent Begins Study To Support Licensure Of BioThrax Production At New Plant
9/23/2014 7:32:00 AM - RTT News


EBS Gets Funded, HPTX Pulls Plug On Diabetes Drug Candidate, Panther On The Mend
9/8/2014 11:10:00 PM - RTT News